PPBT – purple biotech ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
Purple Biotech Announces Plan to Implement ADS Ratio Change
Purple Biotech Achieves Toxicology Milestone Demonstrating an Expanded Therapeutic Window for CAPTN-3 Platform Tri-specific Antibody, IM1240
Purple Biotech (NASDAQ:PPBT) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Purple Biotech Reports Positive New Preclinical Data Demonstrating Multi-Arm Anti-Tumor Activity Across Two CAPTN-3 Tri-Specific Antibodies at ESMO Immuno-Oncology Congress 2025
Form 6-K PURPLE BIOTECH LTD. For: Feb 25
Form 424B3 Purple Biotech Ltd./ADR
Form SCHEDULE 13G PURPLE BIOTECH LTD. Filed by: SUSQUEHANNA SECURITIES, LLC
Form 6-K PURPLE BIOTECH LTD. For: Jan 12
Form 6-K PURPLE BIOTECH LTD. For: Jan 07
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.